Live from the NIH registry
Studies recruiting near Spring Hill right now
Top 25 of 109 recruiting studies, sorted by proximity — each links to its official registry page
Secukinumab Open Label Roll-over Extension Protocol
Autoimmunity, Inflammation
Phase 4
Interventional 1,000 participants sought
FL Medical Clinic Orlando Health — Zephyrhills, Florida (27.2 mi)
· Sponsor: Novartis Pharmaceuticals
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
COPD, Smoking
N/A
Interventional 290 participants sought
Advanced Research Institute, Inc — New Port Richey, Florida (19.9 mi)
· Sponsor: Philip Morris Products S.A.
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Nature Coast Clinical Research — Inverness, Florida (27.4 mi)
· Sponsor: Janssen Research & Development, LLC
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Uterine Fibroids, Endometriosis
Phase 3
Interventional 1,000 participants sought
New Port Richey — New Port Richey, Florida (19.9 mi)
· Sponsor: Sumitomo Pharma Switzerland GmbH
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
Moffitt Cancer Center at Wesley Chapel — Wesley Chapel, Florida (20.6 mi)
· Sponsor: NRG Oncology
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Heart Failure, Acute Heart Failure
Phase 3
Interventional 5,200 participants sought
Brooksville, FL Investigative Site 10077 — Brooksville, Florida (10.0 mi)
· Sponsor: Colorado Prevention Center
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Pulmonary Disease, Chronic Obstructive
Phase 3
Interventional 960 participants sought
GSK Investigational Site — Brooksville, Florida (10.0 mi)
· Sponsor: GlaxoSmithKline
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — New Port Richey, Florida (19.9 mi)
· Sponsor: Akero Therapeutics, Inc
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
Nature Coast Clinical Research - Inverness — Inverness, Florida (27.4 mi)
· Sponsor: Eli Lilly and Company
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Non-alcoholic Fatty Liver Disease
Phase 3
Interventional 1,250 participants sought
GSK Investigational Site — Inverness, Florida (27.4 mi)
· Sponsor: GlaxoSmithKline
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Type 1 Diabetes Mellitus With Hypoglycemia
Phase 2
Interventional 186 participants sought
Suncoast Clinical Research — New Port Richey, Florida (19.9 mi)
· Sponsor: Zucara Therapeutics Inc.
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Multiple conditions
Phase 2
Interventional 98 participants sought
Moffitt Cancer Center at Wesley Chapel — Wesley Chapel, Florida (20.6 mi)
· Sponsor: NRG Oncology
FebriDx® Pediatric Validation Study
Acute Respiratory Infections (ARIs)
N/A
Observational 800 participants sought
PAS Research- Sandhill Pediatrics PA — Lutz, Florida (23.1 mi)
· Sponsor: Lumos Diagnostics
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 762 participants sought
89bio Clinical Study Site — New Port Richey, Florida (19.9 mi)
· Sponsor: 89bio, Inc.
Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation
Locally Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma
Phase 1, Phase 2
Interventional 37 participants sought
Moffitt Cancer Center at Wesley Chapel — Wesley Chapel, Florida (20.6 mi)
· Sponsor: National Cancer Institute (NCI)
A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
Cardiovascular, Metabolic Disease
Phase 1
Interventional 90 participants sought
Research Site 19 — High Point, Florida (4.6 mi)
· Sponsor: CRISPR Therapeutics AG
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Florida Cancer Specialists North / Sarah Cannon Research Institute — Trinity, Florida (22.6 mi)
· Sponsor: American Society of Clinical Oncology
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Moderately to Severely Active Crohns Disease
Phase 3
Interventional 600 participants sought
Access Research Institute — Brooksville, Florida (10.0 mi)
· Sponsor: Hoffmann-La Roche
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma
Phase 3
Interventional 269 participants sought
Moffitt Cancer Center at Wesley Chapel — Wesley Chapel, Florida (20.6 mi)
· Sponsor: NRG Oncology
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Locally Advanced Cervical Adenocarcinoma, Locally Advanced Cervical Adenosquamous Carcinoma
Phase 3
Interventional 336 participants sought
Moffitt Cancer Center at Wesley Chapel — Wesley Chapel, Florida (20.6 mi)
· Sponsor: National Cancer Institute (NCI)
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Pulmonary Disease, Chronic Obstructive
Phase 3
Interventional 1,196 participants sought
GSK Investigational Site — Crystal River, Florida (29.5 mi)
· Sponsor: GlaxoSmithKline
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
Irritable Bowel Syndrome
Phase 2
Interventional 420 participants sought
GSK Investigational Site — New Port Richey, Florida (19.9 mi)
· Sponsor: GlaxoSmithKline
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features
Phase 3
Interventional 600 participants sought
Moffitt Cancer Center at Wesley Chapel — Wesley Chapel, Florida (20.6 mi)
· Sponsor: National Cancer Institute (NCI)
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
Asthma
Phase 3
Interventional 150 participants sought
GSK Investigational Site — Brooksville, Florida (10.0 mi)
· Sponsor: GlaxoSmithKline
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Intestinal Neoplasms, Gastrointestinal Neoplasms
Phase 3
Interventional 800 participants sought
Comprehensive Hematology Oncology — Trinity, Florida (22.6 mi)
· Sponsor: Pfizer